当前位置:
X-MOL 学术
›
Blood Cancer J.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation.
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2022-04-20 , DOI: 10.1038/s41408-022-00667-9 Shady Adnan Awad 1, 2, 3, 4 , Oscar Brück 1, 2, 3 , Naranie Shanmuganathan 5, 6, 7, 8, 9 , Timo Jarvinen 1, 2 , Hanna Lähteenmäki 1, 2 , Jay Klievink 1, 2 , Hazem Ibrahim 10 , Soili Kytölä 11 , Perttu Koskenvesa 1 , Timothy P Hughes 5, 7, 9 , Susan Branford 6, 7, 8, 9 , Matti Kankainen 1, 2, 3 , Satu Mustjoki 1, 2, 3
中文翻译:
慢性粒细胞白血病 (CML) 诊断时的表观遗传修饰基因突变与治疗停止后复发的风险相关。
更新日期:2022-04-20
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2022-04-20 , DOI: 10.1038/s41408-022-00667-9 Shady Adnan Awad 1, 2, 3, 4 , Oscar Brück 1, 2, 3 , Naranie Shanmuganathan 5, 6, 7, 8, 9 , Timo Jarvinen 1, 2 , Hanna Lähteenmäki 1, 2 , Jay Klievink 1, 2 , Hazem Ibrahim 10 , Soili Kytölä 11 , Perttu Koskenvesa 1 , Timothy P Hughes 5, 7, 9 , Susan Branford 6, 7, 8, 9 , Matti Kankainen 1, 2, 3 , Satu Mustjoki 1, 2, 3
Affiliation
中文翻译:
慢性粒细胞白血病 (CML) 诊断时的表观遗传修饰基因突变与治疗停止后复发的风险相关。